NEW YORK (GenomeWeb News) — Orchid Cellmark yesterday said second-quarter revenue rose 15 percent, R&D spending fell 9 percent, and it slashed its net loss more than five-fold.
Total receipts for the three months ended June 30 increased to $15.7 million from $13.6 million year over year.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.